Private equity firm expects $3.3bn acquisition of Tanabe will get boost from eased approval process for new medicine ...

Farallon presses Astellas to cut costs and overhaul drugs research in latest shareholder campaign gripping Tokyo ...

Pharma companies are “highly ... and an increase in the number of recorded extreme weather events, we are already feeling the effects of climate change. All global industries have a ...

Following rumblings of a private equity bidding war late last year, Bain Capital has emer | Bain Capital is laying out 510 ...

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers ...

TOKYO -- Japan ... Pharmaceutical announced on Thursday that CEO Christophe Weber will step down in June 2026 and be succeeded by current U.S. business head Julie Kim, who would become the company ...

Catalyst Pharmaceuticals, Inc. CORAL GABLES, Fla., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical ...

GlaxoSmithKline (GSK) has firmly acquired the number ... essentials of the pharmaceutical market in Egypt. GSK has understood the game of access in Egypt earlier than other companies.

Takeda Pharmaceutical Company Limited ( NYSE: TAK) Q3 2025 Results Conference Call January 30, 2025 5:30 AM ET Christopher O’Reilly - Head, Investor Relations Christophe Weber - President and Chief ...

TOKYO -- Just ahead of hay fever season's full onset, a Japan pharmaceutical company has released survey results showing that nearly half of elementary and junior high school students in the ...